Last €4.63 EUR
Change Today -0.02 / -0.43%
Volume 50.0
As of 11:30 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

noemalife spa (NOE) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/4/14 - €6.50
52 Week Low
02/24/14 - €3.59
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NOEMALIFE SPA (NOE)

Related News

No related news articles were found.

noemalife spa (NOE) Related Businessweek News

No Related Businessweek News Found

noemalife spa (NOE) Details

NoemaLife S.p.A. provides clinical and hospital information systems for public and private healthcare organizations worldwide. The company offers clinical solutions, such as GALILEO iClinic, a mobile solution for the management of clinical activities at the patient’s bedside; Galileo Dx, an electronic health record/electronic medical record solution; MERCURIO solution for infection control; and GALILEO eWhiteboard solution that enhances the handover of clinical and operational information between health professionals at shift changes. Its clinical solutions also comprise GALILEO EMERGENCY, a software solution for the management of emergency departments; Oncosys oncologic patient management solution; eXacto, an anesthesia recording system; and Galileo Medication, a solution manages prescription and admission medicines workflow. In addition, the company provides diagnostic solutions comprising DNLab laboratory information system that offer laboratory diagnostic solutions; METHIS solution for flow cytometry management; EOS solution for medical genetics laboratories; Athena solution for anatomic pathology; and DNLab Microbiology solution for microbiology labs. Its diagnostic solutions also include HALIA laboratory automation system, which offers a Web based lab computerization solution; ELEKTRA, a digital radiology workflow management solution for the management of radiology, nuclear medicine, and senology department workflows; and DxImage-VIEW and DxImage-PACS for the production and management of medical imaging. Further, the company provides DEMETRA, an oncology screening management solution. NoemaLife S.p.A. was founded in 1996 and is based in Bologna, Italy. NOEMALIFE S.p.A operates as a subsidiary of Ghenos Srl.

Founded in 1996

noemalife spa (NOE) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: €210.0K
Co-Founder and Vice Chairman
Total Annual Compensation: €140.0K
Compensation as of Fiscal Year 2013.

noemalife spa (NOE) Key Developments

NoemaLife Wins Deal to Install Lab Analysis Platform at Turin University Hospital

NoemaLife SpA said it had signed a €2.4 million ($3.1 milion) contract to install a platform for managing the laboratory analysis at Turin's university hospital Citt della Salute e della Scienza di Torino. The six-year contract envisages the setting up of a single laboratory that will group the labs of the three hospitals part of the new Città della Salute e della Scienza: Molinette; OIRM S. Anna; and C.T.O. Maria Adelaide. Under the deal, NoemaLife will also digitalise the prenatal and newborn screening services. NoemaLife's platform for the single laboratory will rationalise acquisitions, prescription application and process management and will introduce overall quality systems.

NoemaLife Wins EUR 2.4 Million Contract from University Hospital 'City of Health and Science of Turin'

NoemaLife has signed a contract worth over EUR 2.4 million with the University Hospital 'City of Health and Science of Turin', for the implementation of a new common IT platform, for the management of the analysis laboratories. The contract provides, for a term of six years, the creation of a Single Logic Laboratory, uniting the laboratories of the three hospitals that have been merged into the City of Health and Science: Molinette; OIRM St. Anna; C.T.O. Maria Adelaide; it also provides for the computerization of pre-natal Screening and neo-natal care.

NoemaLife Group Signs Trade Agreement for the Supply of Electronic Patient Record in the 5 Hospitals of Ariège

The NoemaLife Group announced that it has signed, through its French subsidiary Medasys, a new trade agreement worth EUR 1.5 million for the supply of the Electronic Patient Record in the 5 hospitals of Ariège, the French department in the region of Midi-Pyrenees. This project increases in France, to date 120, the number of hospitals that have chosen solutions developed by Medasys. In particular, the project involves the introduction of an Electronic Patient Record system developed ad hoc by Medasys for the five hospitals in the area of the Ariège - Centre Hospitalier Intercommunal du Val d'Ariège (Saint-Jean-de-Verges), Centre Hospitalier du Olmes (Lavelanet), Centre Hospitalier Ariège couserans (St Girons), the Hôpital Jules Rousse (Tarascon) and the Centre Hospitalier Saint-Louis (Ax-les-Termes) - with the goal of building an integrated computer system in gathering the information of clinical and social nature of the patients coming from different legal entities.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOE:IM €4.63 EUR -0.02

NOE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Health Revenue Assurance Holdings Inc $0.0009 USD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation NOE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 2.5x
Price/Cash Flow 17.5x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOEMALIFE SPA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at